Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

467
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
467
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

477
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
477

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Loss of WNT2B Increases Tumor Burden and Malignant Features in Colorectal Cancer.

Cancer communications (London, England)·2026
Same author

SORBS2 regulates diastolic function through cytoskeletal networks and calcium handling.

Communications biology·2026
Same author

Placental Evidence of Intrauterine Stress: Mechanisms, Timing, and Links to Perinatal Brain Injury.

Journal of clinical medicine·2026
Same author

Drug Induced Liver Injury in Children: Practical Considerations for Pathologists.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
Same author

Childhood-Onset Desmin-Related Cardiomyopathy: Comprehensive Clinical, Histopathological, Immunohistochemical, Ultrastructural, and Molecular Characterization.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
Same author

Chemerin knockout reveals sex difference in the role of chemerin in blood pressure and vascular remodeling.

American journal of physiology. Heart and circulatory physiology·2026
Same journal

A Bundle to Frame Guidelines and American Heart Association Statements.

Circulation·2026
Same journal

<i>Circulation</i> Editors and Editorial Board.

Circulation·2026
Same journal

A New <i>Circulation</i>, For You.

Circulation·2026
Same journal

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Circulation·2026
Same journal

Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023.

Circulation·2026
Same journal

Lipid Profile Testing and Interpretation.

Circulation·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Jun 16, 2025

Pull-down of Calmodulin-binding Proteins
07:51

Pull-down of Calmodulin-binding Proteins

Published on: January 23, 2012

25.3K

Terapia con oligonucleótidos antisenso para la calmodulinopatía

Raul H Bortolin1, Farina Nawar1, Chaehyoung Park1

  • 1Department of Cardiology (R.H.B., F.N., C.P., M.A.T., M.P., M.E.S., P.W., J.C., F.L., C.L., P.B., E.M.K., D.Y., N.P., T.S., Q.M., D.J.A., V.J.B., W.T.P.).

Circulation
|August 19, 2024
PubMed
Resumen
Este resumen es generado por máquina.

Los oligonucleótidos antisenso (ASO) dirigidos a genes específicos de calmodulina son prometedores para el tratamiento de los síndromes de arritmia hereditaria. Este enfoque normalizó efectivamente la función cardíaca en los modelos sin comprometer los niveles esenciales de calmodulina.

Palabras clave:
Oligonucleótido antisensoel calciosíndrome del intervalo QT largoMedicina de precisiónTaquicardia ventricular

Más Videos Relacionados

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.6K
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

13.4K

Videos de Experimentos Relacionados

Last Updated: Jun 16, 2025

Pull-down of Calmodulin-binding Proteins
07:51

Pull-down of Calmodulin-binding Proteins

Published on: January 23, 2012

25.3K
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.6K
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

13.4K

Área de la Ciencia:

  • Genética cardiovascular
  • Cardiología molecular
  • Medicina genética

Sus antecedentes:

  • Las calmodulinopatías son síndromes de arritmias hereditarias raras.
  • Estas condiciones se derivan de las variantes heterocigotas dominantes en los genes CALM1, CALM2 o CALM3, que codifican la proteína calmodulina (CaM).
  • La naturaleza idéntica de la proteína CaM en estos genes presenta un desafío terapéutico.

Objetivo del estudio:

  • Para probar la hipótesis de que el agotamiento mediado por oligonucleótido antisentido (ASO) de un gen de calmodulina afectado podría mejorar las manifestaciones de la enfermedad.
  • Determinar si otros genes de calmodulina podrían preservar los niveles y la función de CaM durante el agotamiento objetivo.
  • Explorar las ASO como una estrategia terapéutica potencial para las calmodulinopatías.

Principales métodos:

  • Se utilizaron cardiomiocitos derivados de células madre pluripotentes inducidas en humanos (hiPSC-CM) y modelos de ratón que albergaban variantes patógenas de CALM1.
  • Se administraron ASO dirigidos a CALM1 en hiPSC-CM y a Calm1 murino en ratones.
  • Efectos evaluados sobre la duración del potencial de acción, la repolarización, los niveles de proteína CaM, los niveles de transcripción y la función eléctrica y contráctil cardíaca.

Principales resultados:

  • Las hiPSC-CM de la variante humana de CALM1 exhibieron potenciales de acción prolongados, modelando el síndrome congénito de QT largo.
  • Los ASO que agotan la CALM1 normalizan la repolarización en los CM hiPSC afectados sin alterar los niveles de proteína CaM.
  • La ASO dirigida a Calm1 murino agotó la transcripción de Calm1, alivió la taquicardia ventricular inducida por el fármaco en ratones y no afectó la función cardíaca.

Conclusiones:

  • Prueba de concepto demostrada para la terapia mediada por ASO en las calmodulinopatías.
  • Los ASO dirigidos a genes individuales de calmodulina son tratamientos potencialmente efectivos.
  • Esta estrategia terapéutica parece segura, preservando los niveles generales de CaM y la función cardíaca.